These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1053885)

  • 21. Anti-factor-VIII inhibitors in haemophilia.
    Lancet; 1989 Aug; 2(8659):363-4. PubMed ID: 2569554
    [No Abstract]   [Full Text] [Related]  

  • 22. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
    Miranda ML; Lissen E; Vinuesa M; Jiménez JM; García de Pesquera F; Leal M
    Med Clin (Barc); 1985 Apr; 84(13):516-9. PubMed ID: 3923278
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of large-scale fractionation methods. 3. Preparation of a factor VIII concentrate of intermediate-purity.
    James HL; Wickerhauser M
    Vox Sang; 1972; 23(5):402-12. PubMed ID: 5077739
    [No Abstract]   [Full Text] [Related]  

  • 24. Activated F IX concentrate (FEIBA) used in the treatment of haemophilic patients with antibody to F VIII.
    Stenbjerg S; Jørgensen J
    Acta Med Scand; 1978; 203(6):471-6. PubMed ID: 665313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors, what is the risk of treatment intensity?
    Collins PW
    J Thromb Haemost; 2007 Jul; 5(7):1380-2. PubMed ID: 17445122
    [No Abstract]   [Full Text] [Related]  

  • 26. Current concepts in the management of hemophilia.
    Abildgaard CF
    Semin Hematol; 1975 Jul; 12(3):223-32. PubMed ID: 1079631
    [No Abstract]   [Full Text] [Related]  

  • 27. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
    Lowe GD; Harvie A; Forbes CD; Prentice CR
    Br Med J; 1976 Nov; 2(6044):1110-1. PubMed ID: 990791
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Prothrombin complex to treat factor VIII inhibition.
    Tishkoff GH
    N Engl J Med; 1975 Apr; 292(14):754-5. PubMed ID: 1113790
    [No Abstract]   [Full Text] [Related]  

  • 31. Complications of hemophilia A treatment: factor VIII inhibitors.
    Kasper CK
    Ann N Y Acad Sci; 1991; 614():97-105. PubMed ID: 1902643
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-factor VIII anamnesis after factor IX complex.
    Palascak JE; Shapiro SR
    N Engl J Med; 1977 Dec; 297(25):1403. PubMed ID: 927458
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII inhibitors, natural history and management.
    Allain JP
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):241-2. PubMed ID: 524148
    [No Abstract]   [Full Text] [Related]  

  • 36. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Concentrates of clotting-factor IX.
    Mannucci PM; Bader R; Ruggeri ZM
    Lancet; 1976 Jan; 1(7949):41. PubMed ID: 54544
    [No Abstract]   [Full Text] [Related]  

  • 38. Factor VIII brand and immunogenicity.
    Ragni MV
    Blood; 2014 Nov; 124(23):3337-8. PubMed ID: 25431473
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgical hemostasis in a hemophiliac using blockade of the inhibitor system.
    MacPherson BH; Drayton NE; Reid WO
    Am Surg; 1974 Apr; 40(4):224-8. PubMed ID: 4815881
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia.
    Hruby MA; Schulman I
    Blood; 1973 Dec; 42(6):919-23. PubMed ID: 4759918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.